Hesperidin
Based on 36 publication(s) in Google Scholar
Hesperidin (Hesperetin 7-rutinoside), a flavanone glycoside, is isolated from citrus fruits. Hesperidin has numerous biological properties, such as decreasing inflammatory mediators and exerting significant antioxidant effects. Hesperidin also exhibits antitumor and antiallergic activities.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.14%
- CAS. Nr.: 520-26-3
- Formel: C28H34O15
- Molecular Weight:610.56
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Hesperidin
More- Nat Commun. 2024 Sep 16;15(1):8130. [Abstract]
- Metabolism. 2025 Aug:169:156271. [Abstract]
- Acta Pharm Sin B. 2021 Jan;11(1):143-155. [Abstract]
- Cell Rep Med. 2025 Aug 19;6(8):102260. [Abstract]
- Cell Death Dis. 2026 Jun 15. [Abstract]
- Cell Death Dis. 2026 Apr 14;17(1):503. [Abstract]
- Phytomedicine. 2026 Jul 25:157:158317. [Abstract]
- Phytomedicine. 2025 May:140:156484. [Abstract]
- Food Chem. 2025 Dec 30:497:146992. [Abstract]
- Food Chem. 2025 Oct 15:489:144992. [Abstract]
- Int J Biol Macromol. 2025 Jul 5;320(Pt 1):145750. [Abstract]
- Phytother Res. 2026 Jun;40(6):3595-3612. [Abstract]
- Phytother Res. 2025 Sep 27. [Abstract]
- Cell Rep. 2017 Nov 21;21(8):2147-2159. [Abstract]
- Chin Med. 2022 Feb 18;17(1):23. [Abstract]
- Ind Crops Prod. 2026 May 8;246:123392.
- Ind Crops Prod. 2025 Dec 11;239:122458.
- Drug Des Devel Ther. 2023 Oct 3:17:3047-3060. [Abstract]
- ACS Biomater Sci Eng. 2026 Mar 9;12(3):1826-1847. [Abstract]
- Nat Prod Bioprospect. 2025 Jun 13;15(1):39. [Abstract]
- Biomolecules. 2022 Nov 25;12(12):1754. [Abstract]
- Int J Mol Sci. 2022 Sep 7;23(18):10346. [Abstract]
- Sci Rep. 2026 Jan 3;16(1):3332. [Abstract]
- Plants. 2024 Dec 4;13(23):3401. [Abstract]
- Dis Model Mech. 2023 Mar 1;16(3):dmm049769. [Abstract]
- Andrology. 2024 Nov 25. [Abstract]
- J Cancer. 2025 Jan 1;16(3):876-887. [Abstract]
- Chem Biol Drug Des. 2025 Feb;105(2):e70032. [Abstract]
- J Neurosci Res. 2019 Dec;97(12):1689-1705. [Abstract]
- Chem Biodivers. 2026 Apr;23(4):e01952. [Abstract]
- Future Sci OA. 2025 Dec;11(1):2483147. [Abstract]
- Biochem Biophys Res Commun. 2023 Sep 3:671:278-285. [Abstract]
- Oncol Lett. 2022 Nov 29;25(1):30. [Abstract]
- J Recept Signal Transduct Res. 2020 Aug;40(4):388-394. [Abstract]
- SSRN. 2025 Jul 8.
- Ann Transl Med. 2020 May;8(10):646. [Abstract]
Customer Validation & Images
-
In Vivo Efficacy Study
-
WB
-
Histological Imaging/Staining
-
RT-PCR
-
WB
Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 3T3-L1 | IC50 |
311 μM
Compound: 11
|
Anticorpulence activity against mouse 3T3L1 cells assessed as inhibition of lipid droplet accumulation
Anticorpulence activity against mouse 3T3L1 cells assessed as inhibition of lipid droplet accumulation
|
[PMID: 19054677] |
| A549 | IC50 |
>100 μM
Compound: 12
|
Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction assay
Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction assay
|
[PMID: 20413315] |
| DLD-1 | IC50 |
>100 μM
Compound: 12
|
Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction assay
Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction assay
|
[PMID: 20413315] |
| H9 | EC50 |
>164 μM
Compound: 21
|
Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay
Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay
|
[PMID: 8158164] |
| H9 | IC50 |
>164 μM
Compound: 21
|
Cytotoxicity against human H9 cells after 3 days
Cytotoxicity against human H9 cells after 3 days
|
[PMID: 8158164] |
| HT-29 | IC50 |
142 μM
Compound: 11
|
Anticancer activity against human HT-29 cells after 72 hrs by MTT assay
Anticancer activity against human HT-29 cells after 72 hrs by MTT assay
|
[PMID: 19054677] |
| Monocyte | IC50 |
>200 μM
Compound: Hesperidin
|
Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
|
[PMID: 10096854] |
Hesperidin (5-200 μM; 24-72 h) induces potent cytotoxic effects in human osteosarcoma MG-63 cells[1].
Hesperidin (5-150 μM; 48 h) induces early and late apoptosis in MG-63 cells[1].
Hesperidin (10-30 μM) inhibits the activity of COX-2 and iNOS in a dose dependent manner in RAW 264.7 cells activated with LPS[2].
Hesperidin (0.1 μg/mL; 2 h) decreases the formation of MDA and intracellular ROS, including chondrocyte apoptosis[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MG-63 cells
-
Concentration:0, 5, 25, 50, 100, 150, 200 µM
-
Incubation Time:24, 48, 72 hours
-
Result:Led to time-dependent and concentration-dependent cytotoxic effects, with IC50s of 94.3, 78.6 and 63.3 µM at 24, 48 and 72 h, respectively.
-
Cell Line:MG-63 cells
-
Concentration:0, 5, 50, 150 µM
-
Incubation Time:48 hours
-
Result:Increased the percentage of apoptotic cells from 4.7% to 17.9, 34.6 and 68.3% at the concentration of 0, 5, 50 and 150 µM, respectively.
Hesperidin (200 mg/kg; once daily for 28 d) markedly attenuates cartilage destruction and reduces IL-1β and TNF-α levels in a surgically-induced osteoarthritis (OA) rats[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 520-26-3
-
Appearance Solid
-
Molecular Weight 610.56
-
Formel C28H34O15
-
Color Light yellow to khaki
-
SMILES
OC1=C(OC)C=CC([C@@H]2CC(C3=C(C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O)O2)=O)=C1
-
Synonyms
Hesperetin 7-rutinoside
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (36)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
Integrative residue-intuitive machine learning and MD Approach to Unveil Allosteric Site and Mechanism for β2AR. [Abstract]2024 Sep 16;15(1):8130. PMID: 39285201 -
Metabolism
WWP1-SHARP1-C/EBPβ positive feedback loop modulates development of metabolic dysfunction-associated steatotic liver disease. [Abstract]2025 Aug:169:156271. PMID: 40280477
Hesperidin purchased from MedChemExpress. Usage Cited in: Metabolism. 2025 Aug:169:156271. [Abstract]
Eight–week–old NTG and OE–WWP1 C57 BL/6 J mice were intragastrically administered with the novel WWP1 inhibitor hesperidin (150 mg/kg body weight/day) and further fed an ND or HFHC for another 16 weeks. Average daily food intake (n = 6/group). Fecal TAG levels (n = 6/group). Liver organ index (n = 6/group). Energy expenditure (n = 6/group). Fasting blood glucose levels, fasting insulin levels, and HOMA–IR scores (n = 6/group).
Hesperidin purchased from MedChemExpress. Usage Cited in: Metabolism. 2025 Aug:169:156271. [Abstract]
Eight–week–old NTG and OE–WWP1 C57 BL/6 J mice were intragastrically administered with the novel WWP1 inhibitor hesperidin (150 mg/kg body weight/day) and further fed an ND or HFHC for another 16 weeks. Western blot analysis of AKT phosphorylation in mouse livers (n = 2/group).
Hesperidin purchased from MedChemExpress. Usage Cited in: Metabolism. 2025 Aug:169:156271. [Abstract]
Eight–week–old NTG and OE–WWP1 C57 BL/6 J mice were intragastrically administered with the novel WWP1 inhibitor hesperidin (150 mg/kg body weight/day) and further fed an ND or HFHC for another 16 weeks. H & E staining of mouse liver sections (n = 6/group). Oil Red O depicting hepatic lipid droplets; scale bar, 50 μm.
Hesperidin purchased from MedChemExpress. Usage Cited in: Metabolism. 2025 Aug:169:156271. [Abstract]
Eight–week–old NTG and OE–WWP1 C57 BL/6 J mice were intragastrically administered with the novel WWP1 inhibitor hesperidin (150 mg/kg body weight/day) and further fed an ND or HFHC for another 16 weeks. RT–qPCR analysis of the mRNA levels of genes involved in hepatic inflammation (n = 6/group).
Hesperidin purchased from MedChemExpress. Usage Cited in: Metabolism. 2025 Aug:169:156271. [Abstract]
Eight–week–old NTG and OE–WWP1 C57 BL/6 J mice were intragastrically administered with the novel WWP1 inhibitor hesperidin (150 mg/kg body weight/day) and further fed an ND or HFHC for another 16 weeks. Western blot detecting expressions of NF–κB pathways in livers (n = 2/group).
-
Acta Pharm Sin B
Chrysin serves as a novel inhibitor of DGK α/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC). [Abstract]2021 Jan;11(1):143-155. PMID: 33532186 -
Cell Rep Med
High-fat diet increases circulating palmitic acid produced by gut Bacteroides thetaiotaomicron to promote thrombosis. [Abstract]2025 Aug 19;6(8):102260. PMID: 40749683 -
Cell Death Dis
2026 Jun 15. PMID: 42297769 -
Cell Death Dis
ANP32E drives lung adenocarcinoma progression via GSK3β-mediated glycolytic reprogramming. [Abstract]2026 Apr 14;17(1):503. PMID: 41980942 -
Phytomedicine
Modified Fuzheng Yiliu Decoction chemosensitizes colorectal cancer by inhibiting cancer stem cell metabolism and stemness through CAV1/ZNF460/GRP78 signaling. [Abstract]2026 Jul 25:157:158317. PMID: 42177885 -
Phytomedicine
Fangchinoline suppresses nasopharyngeal carcinoma progression by inhibiting SQLE to regulate the PI3K/AKT pathway dysregulation. [Abstract]2025 May:140:156484. PMID: 40090046 -
Food Chem
Effects of sun drying combined with baking processes on the flavor quality of Chongqing Tuocha raw tea. [Abstract]2025 Dec 30:497:146992. PMID: 41285060 -
Food Chem
Flavonoid-mediated metabolic underpinning quality variation in red bud-sport pear mutants. [Abstract]2025 Oct 15:489:144992. PMID: 40466530 -
Int J Biol Macromol
Hesperidin mitigates copper nanoparticle exposure-induced mitochondrial unfolded protein response through the SIRT3-FOXO3A signaling pathway. [Abstract]2025 Jul 5;320(Pt 1):145750. PMID: 40617440 -
Phytother Res
Hesperidin Promotes Peripheral Nerve Repair by Inducing Autophagy and Inhibiting Apoptosis via the STAT3/Bcl-2 Pathway. [Abstract]2026 Jun;40(6):3595-3612. PMID: 41945422 -
Phytother Res
Hesperidin Inhibits Oxidative Stress and Apoptosis of Granulosa Cells in Polycystic Ovarian Syndrome Through the JAK2/STAT3 and PI3K/AKT Pathways. [Abstract]2025 Sep 27. PMID: 41014201 -
Cell Rep
SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function. [Abstract]2017 Nov 21;21(8):2147-2159. PMID: 29166606
Hesperidin purchased from MedChemExpress. Usage Cited in: Cell Rep. 2017 Nov 21;21(8):2147-2159. [Abstract]
U2OS cells expressing Myc-tagged PLK1 WT, K492R, or SUMO-1-K492R are treated with NSC 125973 for 16 hr. Half of the cells are then released in the presence of Hesperidin for 45 min to enrich cells at the later stage of M phase. Cell lysates are subject to IP, followed by western blot.
-
Chin Med
Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence. [Abstract]2022 Feb 18;17(1):23. PMID: 35180857 -
-
-
Drug Des Devel Ther
Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway. [Abstract]2023 Oct 3:17:3047-3060. PMID: 37808345 -
ACS Biomater Sci Eng
Hesperidin-Loaded Nanoparticles Attenuate Pathological Angiogenesis in Oxygen-Induced Retinopathy by Modulating the Retinal Immune Microenvironment. [Abstract]2026 Mar 9;12(3):1826-1847. PMID: 41741960 -
Nat Prod Bioprospect
Exploring anti-SARS-CoV-2 natural products: dual-viral target inhibition by delphinidin and the anti-coronaviral efficacy of deapio platycodin D. [Abstract]2025 Jun 13;15(1):39. PMID: 40512442 -
Biomolecules
Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease. [Abstract]2022 Nov 25;12(12):1754. PMID: 36551182 -
Int J Mol Sci
Hesperetin from Root Extract of Clerodendrum petasites S. Moore Inhibits SARS-CoV-2 Spike Protein S1 Subunit-Induced NLRP3 Inflammasome in A549 Lung Cells via Modulation of the Akt/MAPK/AP-1 Pathway. [Abstract]2022 Sep 7;23(18):10346. PMID: 36142258 -
Sci Rep
Hesperetin alleviates sepsis-associated acute respiratory distress syndrome via the PI3K/Akt/PTEN axis. [Abstract]2026 Jan 3;16(1):3332. PMID: 41484432 -
Plants
Determination of Flavonoid Glycoside Isomers Using Vision Transformer and Tandem Mass Spectrometry. [Abstract]2024 Dec 4;13(23):3401. PMID: 39683194 -
Dis Model Mech
A Drosophila chemical screen reveals targeting MEK and DGKa mitigates Ras-driven polarity-impaired tumour growth. [Abstract]2023 Mar 1;16(3):dmm049769. PMID: 36861754 -
Andrology
Therapeutic potential of hesperidin in diabetes mellitus-induced erectile dysfunction through Nrf2-mediated ferroptosis and oxidative stress. [Abstract]2024 Nov 25. PMID: 39587831 -
J Cancer
Hesperidin inhibits colon cancer progression by downregulating SLC5A1 to suppress EGFR phosphorylation. [Abstract]2025 Jan 1;16(3):876-887. PMID: 39781340 -
Chem Biol Drug Des
Potential Modulatory Effects of Hesperidin on the JAK/STAT Pathway in Mesangial Proliferative Glomerulonephritis. [Abstract]2025 Feb;105(2):e70032. PMID: 39928525 -
J Neurosci Res
Enhanced mitochondrial inhibition by 3,4-dihydroxyphenyl-acetaldehyde (DOPAL)-oligomerized α-synuclein. [Abstract]2019 Dec;97(12):1689-1705. PMID: 31420910 -
Chem Biodivers
Rhamnetin Identified as a Potent Multidrug Resistance Reversal Agent From Xinjiang Euphorbia: Integrated Network Pharmacology, Molecular Simulation, and In Vitro Validation. [Abstract]2026 Apr;23(4):e01952. PMID: 42037539 -
Future Sci OA
2025 Dec;11(1):2483147. PMID: 40155367 -
Biochem Biophys Res Commun
Hesperidin inhibits methylation and autophagy in LPS and high glucose-induced human villous trophoblasts. [Abstract]2023 Sep 3:671:278-285. PMID: 37311265 -
Oncol Lett
Hesperidin inhibits tobacco smoke-induced pulmonary cell proliferation and EMT in mouse lung tissues via the p38 signaling pathway. [Abstract]2022 Nov 29;25(1):30. PMID: 36589667 -
J Recept Signal Transduct Res
Function of hesperidin alleviating inflammation and oxidative stress responses in COPD mice might be related to SIRT1/PGC-1α/NF-κB signaling axis. [Abstract]2020 Aug;40(4):388-394. PMID: 32164488 -
-
Ann Transl Med
ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner. [Abstract]2020 May;8(10):646. PMID: 32566583
Lösungsmittel & Löslichkeit
DMSO : 100 mg/mL (163.78 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.09 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (4.09 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (281 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Du GY, et, al. Hesperidin exhibits in vitro and in vivo antitumor effects in human osteosarcoma MG-63 cells and xenograft mice models via inhibition of cell migration and invasion, cell cycle arrest and induction of mitochondrial-mediated apoptosis. Oncol Lett. 2018 Nov;16(5):6299-6306. [Content Brief]
[2]. Tejada S, et, al. Potential Anti-inflammatory Effects of Hesperidin from the Genus Citrus. Curr Med Chem. 2018;25(37):4929-4945. [Content Brief]
[3]. Gao G, et, al. Effects of Hesperidin on H₂O₂-Treated Chondrocytes and Cartilage in a Rat Osteoarthritis Model. Med Sci Monit. 2018 Dec 17;24:9177-9186. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.6378 mL | 8.1892 mL | 16.3784 mL | 40.9460 mL |
| 5 mM | 0.3276 mL | 1.6378 mL | 3.2757 mL | 8.1892 mL | |
| 10 mM | 0.1638 mL | 0.8189 mL | 1.6378 mL | 4.0946 mL | |
| 15 mM | 0.1092 mL | 0.5459 mL | 1.0919 mL | 2.7297 mL | |
| 20 mM | 0.0819 mL | 0.4095 mL | 0.8189 mL | 2.0473 mL | |
| 25 mM | 0.0655 mL | 0.3276 mL | 0.6551 mL | 1.6378 mL | |
| 30 mM | 0.0546 mL | 0.2730 mL | 0.5459 mL | 1.3649 mL | |
| 40 mM | 0.0409 mL | 0.2047 mL | 0.4095 mL | 1.0237 mL | |
| 50 mM | 0.0328 mL | 0.1638 mL | 0.3276 mL | 0.8189 mL | |
| 60 mM | 0.0273 mL | 0.1365 mL | 0.2730 mL | 0.6824 mL | |
| 80 mM | 0.0205 mL | 0.1024 mL | 0.2047 mL | 0.5118 mL | |
| 100 mM | 0.0164 mL | 0.0819 mL | 0.1638 mL | 0.4095 mL |
Hesperidin Related Classifications
HY-15337 Related Classifications
Powered by Bioz